vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.

Tapestry, Inc. is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.9× Everus Construction Group, Inc.). Tapestry, Inc. runs the higher net margin — 17.9% vs 5.5%, a 12.4% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 21.0%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 9.9%).

Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.

ECG vs TPR — Head-to-Head

Bigger by revenue
TPR
TPR
1.9× larger
TPR
$1.9B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+12.2% gap
ECG
33.2%
21.0%
TPR
Higher net margin
TPR
TPR
12.4% more per $
TPR
17.9%
5.5%
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
9.9%
TPR

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ECG
ECG
TPR
TPR
Revenue
$1.0B
$1.9B
Net Profit
$55.3M
$343.8M
Gross Margin
11.6%
76.9%
Operating Margin
6.8%
22.3%
Net Margin
5.5%
17.9%
Revenue YoY
33.2%
21.0%
Net Profit YoY
60.4%
EPS (diluted)
$1.09
$1.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
TPR
TPR
Q1 26
$1.9B
Q4 25
$1.0B
$2.5B
Q3 25
$986.8M
$1.7B
Q2 25
$921.5M
$1.7B
Q1 25
$826.6M
$1.6B
Q4 24
$759.6M
$2.2B
Q3 24
$761.0M
$1.5B
Q2 24
$703.4M
$1.6B
Net Profit
ECG
ECG
TPR
TPR
Q1 26
$343.8M
Q4 25
$55.3M
$561.3M
Q3 25
$57.0M
$274.8M
Q2 25
$52.8M
$-517.1M
Q1 25
$36.7M
$203.3M
Q4 24
$34.5M
$310.4M
Q3 24
$41.8M
$186.6M
Q2 24
$39.0M
$159.3M
Gross Margin
ECG
ECG
TPR
TPR
Q1 26
76.9%
Q4 25
11.6%
75.5%
Q3 25
12.6%
76.3%
Q2 25
13.0%
76.3%
Q1 25
11.2%
76.1%
Q4 24
11.4%
74.4%
Q3 24
11.8%
75.3%
Q2 24
12.6%
74.9%
Operating Margin
ECG
ECG
TPR
TPR
Q1 26
22.3%
Q4 25
6.8%
28.6%
Q3 25
7.3%
19.3%
Q2 25
7.9%
-33.9%
Q1 25
6.2%
16.0%
Q4 24
6.1%
22.4%
Q3 24
7.1%
16.7%
Q2 24
7.3%
14.8%
Net Margin
ECG
ECG
TPR
TPR
Q1 26
17.9%
Q4 25
5.5%
22.4%
Q3 25
5.8%
16.1%
Q2 25
5.7%
-30.0%
Q1 25
4.4%
12.8%
Q4 24
4.5%
14.1%
Q3 24
5.5%
12.4%
Q2 24
5.5%
10.0%
EPS (diluted)
ECG
ECG
TPR
TPR
Q1 26
$1.65
Q4 25
$1.09
$2.68
Q3 25
$1.11
$1.28
Q2 25
$1.03
$-2.30
Q1 25
$0.72
$0.95
Q4 24
$0.68
$1.38
Q3 24
$0.82
$0.79
Q2 24
$0.76
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
TPR
TPR
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$281.5M
$2.4B
Stockholders' EquityBook value
$629.8M
$682.4M
Total Assets
$1.7B
$6.5B
Debt / EquityLower = less leverage
0.45×
3.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
TPR
TPR
Q1 26
$1.1B
Q4 25
$1.1B
Q3 25
$743.2M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$553.0K
$7.3B
Q2 24
$7.2B
Total Debt
ECG
ECG
TPR
TPR
Q1 26
$2.4B
Q4 25
$281.5M
$2.4B
Q3 25
$285.1M
$2.4B
Q2 25
$288.6M
$2.4B
Q1 25
$292.1M
$2.4B
Q4 24
$295.6M
$2.4B
Q3 24
$7.0B
Q2 24
$6.9B
Stockholders' Equity
ECG
ECG
TPR
TPR
Q1 26
$682.4M
Q4 25
$629.8M
$551.2M
Q3 25
$573.0M
$399.5M
Q2 25
$514.4M
$857.8M
Q1 25
$460.2M
$1.5B
Q4 24
$422.6M
$1.3B
Q3 24
$453.3M
$3.0B
Q2 24
$490.0M
$2.9B
Total Assets
ECG
ECG
TPR
TPR
Q1 26
$6.5B
Q4 25
$1.7B
$6.5B
Q3 25
$1.6B
$6.4B
Q2 25
$1.5B
$6.6B
Q1 25
$1.4B
$7.3B
Q4 24
$1.3B
$7.3B
Q3 24
$1.3B
$13.7B
Q2 24
$13.4B
Debt / Equity
ECG
ECG
TPR
TPR
Q1 26
3.48×
Q4 25
0.45×
4.32×
Q3 25
0.50×
5.95×
Q2 25
0.56×
2.77×
Q1 25
0.63×
1.59×
Q4 24
0.70×
1.78×
Q3 24
2.35×
Q2 24
2.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
TPR
TPR
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
TPR
TPR
Q1 26
Q4 25
$48.2M
$1.1B
Q3 25
$76.2M
$112.6M
Q2 25
$25.3M
$446.8M
Q1 25
$7.1M
$144.3M
Q4 24
$506.0M
Q3 24
$78.9M
$119.5M
Q2 24
$256.0M
Free Cash Flow
ECG
ECG
TPR
TPR
Q1 26
Q4 25
$23.5M
$1.0B
Q3 25
$65.7M
$80.2M
Q2 25
$12.3M
$411.5M
Q1 25
$-11.4M
$113.4M
Q4 24
$475.1M
Q3 24
$60.9M
$93.9M
Q2 24
$209.8M
FCF Margin
ECG
ECG
TPR
TPR
Q1 26
Q4 25
2.3%
41.5%
Q3 25
6.7%
4.7%
Q2 25
1.3%
23.9%
Q1 25
-1.4%
7.2%
Q4 24
21.6%
Q3 24
8.0%
6.2%
Q2 24
13.2%
Capex Intensity
ECG
ECG
TPR
TPR
Q1 26
Q4 25
2.4%
1.7%
Q3 25
1.1%
1.9%
Q2 25
1.4%
2.0%
Q1 25
2.2%
2.0%
Q4 24
1.4%
Q3 24
2.4%
1.7%
Q2 24
2.9%
Cash Conversion
ECG
ECG
TPR
TPR
Q1 26
Q4 25
0.87×
1.93×
Q3 25
1.34×
0.41×
Q2 25
0.48×
Q1 25
0.19×
0.71×
Q4 24
1.63×
Q3 24
1.89×
0.64×
Q2 24
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

TPR
TPR

Segment breakdown not available.

Related Comparisons